Navigation Links
Isis Reports Financial Results and Highlights for Second Quarter 2013
Date:8/6/2013

d timing of payments under agreements with Isis' partners, including license fees, milestone-related payments and other payments. For example, Isis earned nearly $50 million in milestone and licensing payments in the first half of 2013 comprised of:

  • $25 million from Genzyme when the FDA approved the KYNAMRO™ NDA;
  • $10 million when AstraZeneca added a second development candidate, ISIS-ARRx, to its collaboration with Isis;
  • $7.5 million from GlaxoSmithKline when Isis initiated the Phase 2/3 study of ISIS-TTRRx;
  • $3.5 million from Biogen Idec when Isis dosed the first infant in a Phase 2 study of ISIS-SMNRx; and
  • $3.5 million when Xenon licensed a development candidate, XEN701, from Isis.
  • In comparison, Isis earned a $25 million milestone payment in the first half of 2012 from Genzyme when the FDA accepted the NDA for KYNAMRO.  Isis' revenue in the first half of 2013 also included more than $13 million in new revenue Isis earned from its alliances with AstraZeneca, Biogen Idec and Roche.  These increases were offset, in part, by the completion of the amortization of the upfront payments associated with Isis' Genzyme collaboration. 

    Operating Expenses
    On a pro forma basis, Isis' operating expenses of $43.4 million and $82.3 million for the three and six months ended June 30, 2013, respectively, were nearly flat compared to $41.2 million and $80.6 million for the same periods in 2012. 

    On a GAAP basis, Isis' operating expenses for the three and six months ended June 30, 2013 were $46.0 million and $87.8 million, respectively, compared to $43.6 million and $85.3 million for the same periods in 2012. 

    Net Loss
    Isis reported a net loss of $10.1 million and $11.8 million for the three and six months ended June 30, 2013, respectively, compared to $1.2 million and $25.2 million for the same periods in 2012.  Basi
    '/>"/>

    SOURCE Isis Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. CVS Caremark Reports Record Second Quarter Results
    2. BioLineRx Reports Second Quarter 2013 Results
    3. Regeneron Reports Second Quarter 2013 Financial and Operating Results
    4. Cytos Biotechnology Ltd Reports Second Quarter 2013 Financial Results and Recent Developments
    5. Volcano Reports Second Quarter Results; Medical Segment Revenues Increase More Than 13 Percent On A Constant Currency Basis
    6. Landauer, Inc. Reports Fiscal 2013 Third Quarter Results
    7. PDI Reports 2013 Second Quarter Financial Results
    8. U.S. Orthopedic Biomaterials Market & Global Biomaterials Industry Reviewed by Products and Applications in New Research Reports
    9. Isis Pharmaceuticals Reports Data From a Phase 2 Study of Isis-CRP Rx in Patients with Rheumatoid Arthritis
    10. GW Pharmaceuticals plc Reports 2013 Third Quarter Financial Results
    11. Neuland Labs Reports First Quarter Fiscal Year 2014 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2015)... 28, 2015  Today, in final recognition of the ... Health Week, 1-800 Contacts is sharing how to keep ... lens wearers who do not properly care for their ... infections. Most contact lens wearers understand ... clean lens case is sometimes overlooked.  When proper steps ...
    (Date:8/28/2015)... 28, 2015 Research ... addition of the "Investigation Report on China,s ... Developed by Pharmacia & Upjohn in ... which effectively reduces intraocular pressure. As the first ... the trade name of Xalatan) entered ...
    (Date:8/28/2015)... , Aug. 28, 2015 Perrigo Company plc ... the Mylan N.V. ("Mylan") (NASDAQ: MYL ) shareholder ... "Our views of Mylan,s offer to Perrigo ... based on our Board,s careful reflection of the value ... the limited choices that Mylan has allowed its shareholders ...
    Breaking Medicine Technology:1-800 Contacts Shares Tips on How to Clean Lens Cases 2China Latanoprost Market Investigation Report 2015-2019 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5
    ... STEWARTVILLE, Minn., Jan. 12, 2011 Rochester Medical Corporation ... reached an agreement with Fornix N.V. to purchase from ... supplies distribution company located in Beuningen, The Netherlands.  Laprolan ... the Dutch market and had unaudited revenues of approximately ...
    ... 12, 2011 Mayer Laboratories, Inc., a marketer of high-quality contraceptives ... the US, Canada and the EU, announced today that the Today ... exclusively at all Shoppers Drug Mart locations in Canada. Shoppers ... t has 1,149 stores in nine provinces and ...
    Cached Medicine Technology:Rochester Medical Corporation Announces Agreement to Acquire Laprolan B.V. 2Rochester Medical Corporation Announces Agreement to Acquire Laprolan B.V. 3Today® Sponge Returns to Store Shelves in Canada 2
    (Date:8/30/2015)... Fl (PRWEB) , ... August 30, 2015 , ... ... Spector has joined the company as the new Global Communications Director for InHealth ... public relations experience having spent the last 16 years doing on-air television, producing ...
    (Date:8/30/2015)... (PRWEB) , ... August 30, 2015 , ... Natural Rest ... beneficial effects as sleep aids and calming remedies, which help to improve mood disorders ... of a great deal of research in the field of regenerative medicine conducted by ...
    (Date:8/30/2015)... ... August 30, 2015 , ... Certified Nutrition Businessman Reid Eckert agrees ... and InHealth media is a global sales and communications firm that offers U.S. brands ... continue our business relationship with Mr. Reid Eckert, as his interpretation of the nutritional ...
    (Date:8/30/2015)... ... August 30, 2015 , ... Nutritional Products International ... the expansion of global cosmeceutical and skin care brands. Mr. Fernandez comes ... last 25 years working in operations, purchasing and management for some of the ...
    (Date:8/30/2015)... ... August 30, 2015 , ... Nutritional ... from Administrative assistant to Executive Assistant to CEO Mitch Gould for Nutritional Products ... focused on your goals. Kathleen graduated from Florida State University with a ...
    Breaking Medicine News(10 mins):Health News:InHealth Media Appoints New Global Communications Director 2Health News:Creative Medical Health’s Natural Rest® Now Available on ReCreative Medical Health’s Natural Rest® Now Available on RevNutrition.com 2Health News:Nutrition Guru Continues Relationship With Renowned Health and Wellness Company 2Health News:NPI Executive Vice President Leads Cosmeceutical Expansion 2Health News:NPI Appoints New Executive Assistant To CEO 2
    ... , FRIDAY, Dec. 30 (HealthDay News) -- ... and skaters should take simple safety precautions, orthopedic experts ... that in 2010 more than 440,000 people were treated ... among snowboarders and skiers. These two sports accounted for ...
    ... Two recent studies by Van Andel Research Institute scientists ... distinct kidney cancer subtypes, which could pave the way for ... Cell led by Kyle Furge, Ph.D. and Aikseng Ooi, ... of Type 2 papillary renal cell carcinoma (PRCC2), an aggressive ...
    ... Dennis Thompson HealthDay Reporter , THURSDAY, Dec. 29 (HealthDay ... was 19 years old. Then a sophomore studying physics at ... and depression for years. He said he,d self-medicated by drinking and ... demons that had been gnawing at his soul for years burst ...
    ... 2011 revision of the International Standards for the Neurological ... the November 2011 issue of the Journal of ... Steven Kirshblum et al clarifies the modifications to this ... http://www.ingentaconnect.com/content/maney/scm (#6, Nov 2011). ISNCSCI ...
    ... -- A new review of existing research suggests that, despite ... heart patients should get Plavix, a blood-thinning drug used to ... clopidogrel, is used to treat or prevent blood clots due ... as balloon angioplasty. But some patients ...
    ... Dennis Thompson HealthDay Reporter , WEDNESDAY, Dec. 28 ... are typically thought to be diseases of young women and ... drive a young person to an eating disorder may linger ... are coming forward to receive treatment for eating problems that ...
    Cached Medicine News:Health News:Tips to Keep Winter Sports Injury-Free 2Health News:Tips to Keep Winter Sports Injury-Free 3Health News:Van Andel Research Institute findings provide more complete picture of kidney cancer 2Health News:Virginia Man Won't Let His Mental Illness Define Him 2Health News:JSCM publishes revised International Standards for Neurological Classification of Spinal Cord Injury 2Health News:Doubt Cast on Use of Genetic Test Before Plavix 2Health News:Eating Disorders Can Last Well Beyond Teen Years 2Health News:Eating Disorders Can Last Well Beyond Teen Years 3
    Tennant straight tying forceps with extra delicate smooth jaws, 6 mm tying platform, For 9-0 to 11-0 sutures. Overall length 108 mm....
    Kelman - McPherson angled tying forceps is long with tying platform 10 mm, serrated handle and polished finish....
    Castroviejo tying forceps, straight....
    Gerl titanium tying forceps has curved shanks, smooth jaws and 6 mm long tying platform. For 8-0 to 11-0 sutures....
    Medicine Products: